Show Me Your Care Plan™: Navigating Biomarkers to Guide and Support NSCLC Care

Activity Overview

This online, on-demand virtual symposium brings together renowned experts in non–small cell lung cancer (NSCLC). In this educational program, these experts use a combination of didactic presentations and case-based discussions to examine biomarker testing, then move through targeted therapy updates across key biomarker-driven subtypes, with a focus on adverse event recognition and management strategies relevant to the practicing nurse. Case conversations give the audience practical takeaways to support adherence to novel therapies, guide clinical trial conversations, and navigate the nuanced toxicity profiles of next-generation agents.

This educational activity is an archive of the live symposium held on August 20, 2026.

Target Audience

This educational activity is directed toward oncology nurses, nurse practitioners, physicians, and other advanced practice providers who manage patients with NSCLC.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

• Describe testing indications, key biomarkers, and the nursing role in comprehensive molecular testing for patients with NSCLC
• Apply best practices for adverse event prevention, monitoring, and intervention for patients with NSCLC receiving targeted therapy
• Implement strategies to explain biomarker testing, manage expectations with new therapies, and support shared decision-making for patients with NSCLC

The staff of Physicians’ Education Resource^®, LLC, have no relevant financial relationships with ineligible companies.

PER^® mitigated all conflicts of interest for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This accredited continuing education activity was planned in accordance with the ACCME Standards for Integrity and Independence to ensure balance, objectivity, independence, and scientific rigor. Faculty were instructed to use generic names when possible and to base recommendations on the best available evidence. Proprietary product names may be referenced in clinical discussion for educational purposes only and do not imply endorsement.

This activity may include discussion of investigational, unapproved, or off‑label uses of drugs or devices. Learners are advised to consult prescribing information for products discussed. Content is provided for educational purposes only and is not a substitute for the independent clinical judgment of a health care professional. Learners are encouraged to critically evaluate the information presented and apply their own clinical judgment.

The views expressed are those of the individual faculty members and do not necessarily reflect the views of the accredited provider or any entity providing commercial support.

This activity may have used AI-assisted tools to support educational development. All content was reviewed and approved by qualified faculty or planners. The accredited provider retains full responsibility for accuracy, balance, and independence.